Longyi blood glucose test system - Taiwan Registration d3ab31442de986d6077f83dc895ba08f
Access comprehensive regulatory information for Longyi blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d3ab31442de986d6077f83dc895ba08f and manufactured by Taibo Technology Co., Ltd. five-stock factory. The authorized representative in Taiwan is DRAGON PHARMACEUTICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including Longsheng Pharmaceutical Co., Ltd.;; Taibo Technology Co., Ltd. five stock factory, Taibo Technology Co., Ltd. five-stock factory, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
d3ab31442de986d6077f83dc895ba08f
DHY00500197400
Product Details
Longyi blood glucose test system provides quantitative blood glucose testing, which is suitable for self-measurement of blood sugar by diabetic patients or blood glucose testing by medical professionals. This system is suitable for fresh microvascular blood for blood glucose detection.
A Clinical chemistry and clinical toxicology
A.1345 Glucose Test System
Domestic
Dates and Status
Jan 17, 2006
Jan 17, 2011
Nov 09, 2012
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ
Longyi blood glucose test system
Longsheng Pharmaceutical Co., Ltd.;; Taibo Technology Co., Ltd. five stock factory
63e6f84aa9c15a2221135eb828d00c52
2
Longyi blood glucose test system
Taibo Technology Co., Ltd. five-stock factory
40856a5d717555f06006d0b1f530212a
2